Back to Authors

Harten, Argonde C. van

https://orcid.org/0000-0002-1477-8724

Mayo Clinic

Mayo Clinic

Citations 17

O2‐04‐05: CSF BIOMARKERS IN THE GENERAL POPULATION: ASSOCIATIONS WITH DEMOGRAPHICS AND APOE GENOTYPE
Wiste, Heather J. , Weigand, Stephen D. , Eichenlaub, Udo, Batrla‐Utermann, Richard, Petersen, Ronald C. , Harten, Argonde C. van , Mielke, Michelle M. , Kremers, Walter K. , Knopman, David S. , Jack, Clifford R.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2018.06.2661 Get It

F2‐02‐01: NEUROFILAMENT LIGHT CHAIN IN AD IN CSF AND BLOOD
Syrjanen, Jeremy A. , Blennow, Kaj , Hagen, Clinton E., Petersen, Ronald C. , Kern, Silke , Zetterberg, Henrik , Skoog, Ingmar , Wærn, Margda , Harten, Argonde C. van , Knopman, David S. , Jack, Clifford R. , Mielke, Michelle M.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2018.06.2615 Get It

P2‐273: CEREBROSPINAL FLUID NEUROFILAMENT LIGHT PROTEIN AND RISK OF MILD COGNITIVE IMPAIRMENT IN THE MAYO CLINIC STUDY OF AGING
Syrjanen, Jeremy A. , Blennow, Kaj , Hagen, Clinton E., Petersen, Ronald C. , Kern, Silke , Zetterberg, Henrik , Skoog, Ingmar , Wærn, Margda , Harten, Argonde C. van , Knopman, David S. , Jack, Clifford R. , Mielke, Michelle M.

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2018.06.962 Get It

Subjective cognitive decline and risk of MCI
Harten, Argonde C. van , Swenson-Dravis, Dana M., Hagen, Clinton E., Edwards, Kelly K., Roberts, Rosebud O., Geda, Yonas E. , Petersen, Ronald C. , van Harten, Argonde C, Geda, Yonas E , Mielke, Michelle M. , Knopman, David S.

Neurology | June 29, 2018 | Volume: 91 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000005863 Get It

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
Haeberlein, Samantha Budd , Carrillo, María C. , Hendrix, James A. , Kerchner, Geoff, Margolin, Richard , Maruff, Paul , Tong, Gary, Tome, Maria, Murray, Melissa E. , Nelson, Peter T. , Sano, Mary , Mattsson, Niklas , Sultzer, David L. , Montine, Thomas J. , Jack, Clifford R. , Kolb, Hartmuth C. , Petersen, Ronald C. , Vemuri, Prashanthi , Canniere, Megan Zoschg, Resnick, Susan M. , Romano, Gary, Harten, Argonde C. van , Bain, Lisa J. , Siemers, Eric , Jack, Clifford R , Vemuri, Prashanthi , Murray, Melissa E , Knopman, David S. , Miller, David S. , Schneider, Julie A. , Wolk, David A. , Maruff, Paul

Alzheimer's & Dementia | April 10, 2018 | Volume: 14 | Issue: 4 | Pages: 563-575

10.1016/j.jalz.2018.03.002 Get It

AbstractThe Alzheimer's Association's Research Roundtable met in November 2017 to explore the new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease. The meeting allowed experts in the field from academia, industry, and government to provide perspectives on the new National Institute on Aging and the Alzheimer's Association Research Framework. This review will summarize the “A, T, N System” (Amyloid, Tau, and Neurodegeneration) using biomarkers and how this may be applied to clinical research and drug development. In addition, challenges and barriers to the potential adoption of this new framework will be discussed. Finally, future directions for research will be proposed.
[P4–179]: ASPECTS OF SUBJECTIVE COGNITIVE DECLINE THAT PREDICT INCIDENT MCI IN THE MAYO CLINC STUDY OF AGING
Hagen, Clinton E., Edwards, Kelly K., Swenson-Dravis, Dana M., Roberts, Rosebud O., Petersen, Ronald C. , Harten, Argonde C. van , Mielke, Michelle M. , Knopman, David S. , Geda, Yonas E.

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_28 | Pages: No page available

10.1016/j.jalz.2017.06.2046 Get It

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Jessen, Frank , Amariglio, Rebecca E. , Breteler, Monique M.B. , Ceccaldi, Mathieu , Chételat, Gaël , Dubois, Bruno , Dufouil, Carole , Ellis, Kathryn A. , Flier, Wiesje M. van der , Glodzik, Lidia , Harten, Argonde C. van , Leon, Mony J. de , McHugh, Pauline, Mielke, Michelle M. , Molinuevo, José Luís , Mosconi, Lisa , Osorio, Ricardo S. , Perrotin, Audrey , Petersen, Ronald C. , Rabin, Laura A., Rami, Lorena , Reisberg, ‌Barry , Sachdev, Perminder S. , Sayette, Vincent de La , Saykin, Andrew J. , Scheltens, Philip , Shulman, Melanie , Slavin, Melissa J., Stewart, Robert , Uspenskaya, Olga, Vellas, Bruno , Visser, Pieter Jelle , Wagner, Michael , Group, Subjective Cognitive Decline Initiative (SCD‐I) Working, Boxtel, Martin P.J. van , Rentz, Dorene M. , Sperling, Reisa Anne , Stewart, Robert , Group, Subjective Cognitive Decline Initiative (SCD‐I) Working, Mielke, Michelle M , Saykin, Andrew J , Sachdev, Perminder S , van der Flier, Wiesje M , Scheltens, Philip , Molinuevo, José Luis

Alzheimer's & Dementia | May 3, 2014 | Volume: 10 | Issue: 6 | Pages: 844-852

10.1016/j.jalz.2014.01.001 Get It

Abstract There is increasing evidence that subjective cognitive decline (SCD) in individuals with unimpaired performance on cognitive tests may represent the first symptomatic manifestation of Alzheimer's disease (AD). The research on SCD in early AD, however, is limited by the absence of common standards. The working group of the Subjective Cognitive Decline Initiative (SCD‐I) addressed this deficiency by reaching consensus on terminology and on a conceptual framework for research on SCD in AD. In this publication, research criteria for SCD in pre‐mild cognitive impairment (MCI) are presented. In addition, a list of core features proposed for reporting in SCD studies is provided, which will enable comparability of research across different settings. Finally, a set of features is presented, which in accordance with current knowledge, increases the likelihood of the presence of preclinical AD in individuals with SCD. This list is referred to as SCD plus .